Top Stock Pick for 2015, page-20

Hi Ozkartman,
The share price will move on the release of the interim data from the STORM trial due out first quarter 2015.
Viralytics is now on the world stage and big pharmas are eagerly awaiting storm trial data.
In the sky news business interview Dr malcolm McColl mentions great results coming through,
very promising results in clinical studies in patients with late stage cancer and pretty encouraging results in oncology in important cancer indications.
Could Dr McColl be referring to STORM trial data due out?